Form 8-K - Current report:
SEC Accession No. 0001493152-25-013635
Filing Date
2025-09-16
Accepted
2025-09-16 08:30:45
Documents
14
Period of Report
2025-09-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 42576
2 EX-10.1 ex10-1.htm EX-10.1 21038
3 GRAPHIC form8-k_001.jpg GRAPHIC 4829
  Complete submission text file 0001493152-25-013635.txt   245588

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE dyai-20250915.xsd EX-101.SCH 3008
5 XBRL LABEL FILE dyai-20250915_lab.xml EX-101.LAB 34239
6 XBRL PRESENTATION FILE dyai-20250915_pre.xml EX-101.PRE 22354
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3694
Mailing Address 1044 NORTH U.S. HIGHWAY ONE SUITE 201 JUPITER FL 33477
Business Address 1044 NORTH U.S. HIGHWAY ONE SUITE 201 JUPITER FL 33477 561-743-8333
DYADIC INTERNATIONAL INC (Filer) CIK: 0001213809 (see all company filings)

EIN.: 450486747 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32513 | Film No.: 251315897
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)